STOCK TITAN

OrthoPediatrics holder sells 302K shares on Sept. 10

A ten percent owner of ORTHOPEDIATRICS CORP sold over 300,000 KIDS shares while retaining more than 6.2 million shares.

(Very High)
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

ORTHOPEDIATRICS CORP (KIDS) had a major shareholder, Squadron Capital LLC, report the sale of 302,369 shares of common stock on September 10, 2026, at a weighted average price of $21.01 per share, in multiple trades between $21.00 and $21.69. After this sale, Squadron Capital LLC reported holding 6,201,764 shares directly. The sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses, and no Rule 10b5-1 trading plan is reported. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Squadron Capital LLC, Squadron Capital Holdings LLC
Role 10% Owner | 10% Owner
Sold 302,369 shs ($6.35M)
Type Security Shares Price Value
Sale Common Stock F1, F2, F3 302,369 $21.01 $6.35M
Holdings After Transaction: Common Stock — 6,201,764 shares (Direct)
Footnotes (3)
  1. F1. This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.
  2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.69, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3. These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC.
Shares sold 302,369 shares Common stock sale on September 10, 2026 by Squadron Capital LLC
Weighted average sale price $21.01 per share Average price for 302,369 KIDS shares sold on September 10, 2026
Sale price range $21.00–$21.69 per share Range of prices for the multiple transactions comprising the reported sale
Shares held after transaction 6,201,764 shares Direct holdings of Squadron Capital LLC after the September 10, 2026 sale
Rule 10b5-1 plan status No plan reported Document-level checkbox indicates transaction not under Rule 10b5-1 plan
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
ten percent owner regulatory
"Each reporting person is identified as a ten percent owner."
controlling member financial
"Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC."
Rule 10b5-1 regulatory
"No Rule 10b5-1 trading plan is reported for this transaction."
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did a major holder report for KIDS?

A major holder, Squadron Capital LLC, reported selling 302,369 shares of ORTHOPEDIATRICS CORP common stock on September 10, 2026, at a weighted average price of $21.01 per share, in multiple transactions between $21.00 and $21.69.

How many KIDS shares does Squadron Capital LLC hold after the reported sale?

After the reported sale, Squadron Capital LLC holds 6,201,764 shares of ORTHOPEDIATRICS CORP common stock directly, as disclosed in the Form 4 filing.

At what prices were the KIDS shares sold by Squadron Capital LLC?

The 302,369 KIDS shares sold by Squadron Capital LLC on September 10, 2026, were executed at prices ranging from $21.00 to $21.69 per share, with a reported weighted average price of $21.01 per share.

Why did Squadron Capital LLC sell KIDS shares?

The filing states that the sale by Squadron Capital LLC was undertaken to provide additional capital for its other portfolio businesses. No other reasons are given in the disclosure.

Was the KIDS share sale made under a Rule 10b5-1 trading plan?

No. The Form 4 indicates no Rule 10b5-1 trading plan, and there is no footnote stating that the sale was made pursuant to such a plan.

What is Squadron Capital Holdings LLC’s relationship to Squadron Capital LLC in the KIDS filing?

The filing states that Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC, which directly holds the KIDS shares involved in the reported sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Squadron Capital LLC

(Last)(First)(Middle)
18 HARTFORD AVE., PO BOX 223

(Street)
GRANBY CONNECTICUT 06035

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ORTHOPEDIATRICS CORP [ KIDS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
DirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
XForm filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/10/2026S(1)302,369D$21.01(2)6,201,764D(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
1. Name and Address of Reporting Person*
Squadron Capital LLC

(Last)(First)(Middle)
18 HARTFORD AVE., PO BOX 223

(Street)
GRANBY CONNECTICUT 06035

(City)(State)(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Squadron Capital Holdings LLC

(Last)(First)(Middle)
104 S. MICHIGAN AVE.

(Street)
CHICAGO ILLINOIS 60603

(City)(State)(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
Explanation of Responses:
1. This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.69, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
3. These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC.
/s/ David R. Pelizzon, President of Squadron Capital LLC09/11/2026
/s/ Mary Falcon, Manager of Squadron Capital Holdings LLC09/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading